Cervical Myelopathy in Hip Fracture Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorIndiana University
About this trial
Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground level fall hip fracture patients for cervical myelopathy using a history, physical exam, and then offer an MRI if indicated.
Eligibility criteria
Qualifiers
Patient admitted to Eskenazi, Methodist, or IU North hospital for a hip fracture (femoral neck, intertrochanteric, subtrochanteric, or pertrochanteric fracture) that was caused by a ground level fall.
Disqualifiers
Neurologic or cognitive disorder explaining the fall (dementia, Parkinson's disease, delirium, etc.)
Syncopal fall or fall caused by stroke or a heart condition
Trial design
Treatments tested in this trial
- Cervical MRI
- History & Physical Exam
Treatment groups
75 Participants
are divided into 1 treatment groupLocations
3Indiana University North Hospital46032, FishersIndiana, United States
Eskenazi Hospital46202, IndianapolisIndiana, United States
Indiana University Health Methodist Hospital46202, IndianapolisIndiana, United States
Sponsors and collaborators
Indiana University
Lead sponsor
Source ClinicalTrials.gov